Project 2: Understanding Adolescent Trajectories, Exposures and Suscep
项目 2:了解青少年轨迹、暴露和 Suscep
基本信息
- 批准号:9333247
- 负责人:
- 金额:$ 55.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdolescentAdoptedAdultAdvertisingAgeAppalachian RegionAreaBiochemicalBiologicalBiological MarkersCarcinogen ScreeningCarcinogen exposureChemicalsCigaretteCommunicationCompanionsDataDecision MakingDependenceDevelopmentDiabetes MellitusEmerging TechnologiesEnvironmentEnvironmental Risk FactorExposure toFamilyFlavoringFood PreferencesGenesGeneticGenetic MarkersGenetic Predisposition to DiseaseGenetic VariationGenetic studyHealthHealth CommunicationHeritabilityIndustryLongitudinal StudiesMale AdolescentsMarketingMeasuresMentholMetabolicMetabolismNested Case-Control StudyNicotineNicotine DependenceNitrosaminesObesityOhioOral TobaccoOutcomePerceptionPhysiologicalPoliciesPopulationPredispositionPrevalencePrimary PreventionReactionRegulationResearchResearch DesignResearch PriorityResourcesRiskRuralSmokeSmokelessSmokeless TobaccoSmokerSmokingSurveysSwedenTaste PerceptionTestingTimeTobaccoTobacco DependenceTobacco smokingTobacco useToxicant exposureWorkYouthaddictionbasecohortdesignepigenetic markerfamily influencegene environment interactiongenetic risk factormetabolomicsneurobehaviornovelnovel markerpeerpeer influencepreventproduct developmentsnuffsnusspecific biomarkerssynergismtobacco advertisingtobacco regulatory sciencetoxicanttrait
项目摘要
Most smokers and smokeless tobacco (ST) users begin before the age of 18. In adolescents, the prevalence of
ST use has been increasing and the prevalence of dual use for ST use and smoking is high, and even higher
in Ohio than many other states. The current marketing environment will likely make this increase. However,
almost nothing is known about adolescent initiation of ST and dual use with their trajectories to regular use and
dependence; exposures through biomarkers, and; environmental and genetic risk factors. This project ad-
dresses 3 FDA research priorities: 1) "What level of nicotine and other addictive substances in tobacco is associated
with progression to dependence among smokeless tobacco users, including users of chewing tobacco,
snuff, snus, and dissolvable tobacco products?" 2) "What novel biological and physiological markers (including
genetic and epigenetic markers) are predictive of smoking-related and smokeless tobacco-related adverse.
health outcomes?" 3) How does genetic variation in sensitivity to flavorings and taste influence tobacco
addiction?" To do this, we will follow a cohort of adolescents and establish their trajectories from experimentation
to regular use and dependence, their degree of nicotine exposure with biochemical confirmation, and their
level of nicotine dependence (n=2,010, including a projected 661 tobacco users at the end of the study). We
will measure carcinogen exposures and with concurrent cohort and family based association designs, we will
consider various genetic risk factors. The Specific Aims are: 1) To determine the time from experimentation to
regular use/dependence for tobacco products (smoking, ST and dual use, including new and emerging products),
based on nicotine levels in products and adjusted for predictors of initiation from the environment (e.g.,
family and peer tobacco use, advertising and media). We hypothesize that the time to regular use and dependence
is less for dual users than for exclusive ST use or smoking. 2) To determine the differences in exposure
to tobacco toxicants for daily or almost daily ST users, smokers, and dual users among adolescents using
conventional and novel biomarkers of exposure (e.g. metabolomics). We hypothesize that exposures in dual
users are higher than for ST users or smokers. 3) To identify genetics of susceptibility that influence ST use,
smoking and dual use, i.e., the nicotine metabolic ratio and genes of nicotine metabolism, neurobehavior and
taste perception. We hypothesize that genetic susceptibilities and gene-environment interactions leads to increased
initiation and type of tobacco use, including dual use. The field work will be conducted by the Research,
Survey and Retention Core, and using the same cohort to be studied in companion Project 1, providing
a rich resource for information about exposure to marketing and perceptions. To enhance the generalizability
of our research results, we will study both rural and urban adolescent males, and their families. We will enhance
synergy among the projects that use shared measures. The information from this study will help FDA
decision making about what restrictions, if any, to place on the marketing of tobacco products in the context of
youth initiation and dual use, the regulation of tobacco marketing and promotion, the decision to target healthrelated
communications to adolescents susceptible to dual use, development of product standards related to
exposures and flavorings, and the development of better tests to identify tobacco-related health risks.
大多数吸烟者和无烟烟草 (ST) 使用者在 18 岁之前开始吸烟。在青少年中,
无烟烟草的使用一直在增加,无烟烟草和吸烟双重使用的流行率很高,甚至更高
俄亥俄州比许多其他州都多。当前的营销环境可能会促使这一增长。然而,
关于青少年开始使用 ST 和双重使用及其到定期使用和使用的轨迹几乎一无所知
依赖;通过生物标志物进行暴露;环境和遗传风险因素。该项目广告
FDA 的 3 个研究重点:1)“烟草中尼古丁和其他成瘾物质的含量与什么水平相关?”
随着无烟烟草使用者(包括咀嚼烟草使用者)逐渐形成依赖,
鼻烟、鼻烟和可溶解烟草制品?” 2) “有哪些新颖的生物和生理标记(包括
遗传和表观遗传标记)可以预测与吸烟相关和无烟烟草相关的不良反应。
健康结果?” 3) 对调味品和味道的敏感性的遗传变异如何影响烟草
成瘾?”为此,我们将跟踪一群青少年并通过实验确定他们的轨迹
经常使用和依赖,通过生化确认的尼古丁暴露程度,以及他们的尼古丁暴露程度
尼古丁依赖程度(n=2,010,包括研究结束时预计的 661 名烟草使用者)。我们
将测量致癌物暴露,并通过同时队列和基于家庭的关联设计,我们将
考虑各种遗传风险因素。具体目标是: 1) 确定从实验到
经常使用/依赖烟草制品(吸烟、无烟烟草和双重用途,包括新产品和新兴产品),
基于产品中的尼古丁含量,并根据环境中起始的预测因素进行调整(例如,
家庭和同伴烟草使用、广告和媒体)。我们假设定期使用和依赖的时间
对于双重用户来说,比单独使用 ST 或吸烟时要少。 2) 确定曝光差异
每天或几乎每天使用 ST 的人、吸烟者和青少年中双重使用者的烟草毒物
传统和新颖的暴露生物标志物(例如代谢组学)。我们假设双重暴露
使用者的比例高于 ST 使用者或吸烟者。 3) 确定影响 ST 使用的易感性遗传学,
吸烟和双重使用,即尼古丁代谢比率和尼古丁代谢基因、神经行为和
味觉感知。我们假设遗传易感性和基因-环境相互作用导致增加
烟草使用的开始和类型,包括双重使用。实地工作将由研究机构进行,
调查和保留核心,并使用同一队列在配套项目 1 中进行研究,提供
有关营销和认知的信息的丰富资源。增强普遍性
根据我们的研究成果,我们将研究农村和城市的男性青少年及其家庭。我们将加强
使用共享措施的项目之间的协同作用。这项研究的信息将帮助 FDA
就在以下情况下对烟草制品的营销施加哪些限制(如果有)做出决定
青少年启动和双重使用、烟草营销和促销的监管、以健康相关为目标的决定
与易受双重用途影响的青少年进行沟通,制定相关产品标准
接触和调味品,以及开发更好的测试来识别与烟草相关的健康风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter G. Shields其他文献
Biochemical and molecular epidemiology of cancer.
癌症的生化和分子流行病学。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:0
- 作者:
Haruhiko Sugimura;Ainsley Weston;Neil E. Caporaso;Peter G. Shields;Elise D. Bowman;Metcalf Ra;Curtis C. Harris - 通讯作者:
Curtis C. Harris
Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active treatment, but maintenance of pre-existing antibody levels against endemic viruses.
在接受积极治疗的 B 细胞恶性肿瘤患者中进行 mRNA 疫苗接种和加强接种后,可抑制针对 SARS-CoV2 和 Omicron 变体的从头抗体反应,但维持针对地方性病毒的现有抗体水平。
- DOI:
10.1101/2022.03.17.22272389 - 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Joseph H. Azar;John P. Evans;M. Sikorski;K. Chakravarthy;Selah McKenney;I. Carmody;C. Zeng;Rachael Teodorescu;No;Jamie L. Hamon;D. Bucci;M. Velegraki;Chelsea M Bolyard;Kevin P. Weller;Sarah;Reisinger;S. Bhat;K. Maddocks;R. Gumina;N. Anastasia;Vlasova;E. Oltz;L. Saif;D. Chung;J. Woyach;Peter G. Shields;Shan;Zihai Li;M. Rubinstein - 通讯作者:
M. Rubinstein
Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking.
酪氨酸羟化酶遗传多态性与吸烟缺乏关联。
- DOI:
10.1097/00008571-199712000-00012 - 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
C. Lerman;Peter G. Shields;D. Main;J. Audrain;Joan Roth;Neil R. Boyd;Neil E. Caporaso - 通讯作者:
Neil E. Caporaso
Extraction of breast cancer related biomarkers in T1 weighted MR images of a rodent model
啮齿动物模型 T1 加权 MR 图像中乳腺癌相关生物标志物的提取
- DOI:
10.1109/lssa.2007.4400936 - 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Bin Wang;J. Xuan;Matthew T. Freedman;Peter G. Shields;Y. Wang - 通讯作者:
Y. Wang
Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
细胞色素 P450IIE1 遗传多态性、种族变异和肺癌风险。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:11.2
- 作者:
Shunji Kato;Peter G. Shields;Neil E. Caporaso;Robert N. Hoover;Benjamin F. Trump;Haruhiko Sugimura;Ainsley Weston;Curtis C. Harris - 通讯作者:
Curtis C. Harris
Peter G. Shields的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter G. Shields', 18)}}的其他基金
The Ohio State University Tobacco Center of Regulatory Science (OSU-TCORS)
俄亥俄州立大学烟草监管科学中心 (OSU-TCORS)
- 批准号:
10666066 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Project 1: Urban and Rural Male Youth Cohort Study of Tobacco Use
项目1:城乡男性青少年烟草使用队列研究
- 批准号:
9333246 - 财政年份:2017
- 资助金额:
$ 55.13万 - 项目类别:
The Effects of a Standardized Research E-Cigarette On The Human Lung: A Clinical Trial With Bronchoscopic Biomarkers
标准化研究电子烟对人肺的影响:支气管镜生物标志物的临床试验
- 批准号:
9476111 - 财政年份:2017
- 资助金额:
$ 55.13万 - 项目类别:
Project 4: Comprehension of Health Risks in More and Less Arousing Affe
项目四:在或多或少引发的情感中理解健康风险
- 批准号:
9333249 - 财政年份:2017
- 资助金额:
$ 55.13万 - 项目类别:
Project 1: Urban and Rural Male Youth Cohort Study of Tobacco Use p138-171
项目1:城乡男性青少年烟草使用队列研究 p138-171
- 批准号:
8595671 - 财政年份:2013
- 资助金额:
$ 55.13万 - 项目类别:
Core D: Developmental/Pilot Research Core p367-377
核心 D:发展/试点研究核心 p367-377
- 批准号:
8595688 - 财政年份:2013
- 资助金额:
$ 55.13万 - 项目类别:
相似国自然基金
氧化应激通过m6A修饰下调凹侧肌肉干细胞ESR1表达在青少年特发性脊柱侧凸中的机制研究
- 批准号:82302657
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期母体免疫激活通过阴道菌群垂直传递并损伤子代血脑屏障促进青少年抑郁易感的作用与机制
- 批准号:82371550
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ZMYND10基因突变通过IGF信号通路调控DNAAFs功能在青少年特发性脊柱侧凸中的致病作用及机制研究
- 批准号:82360419
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
FUS通过调控ATP6V1C2表达参与青少年型肌萎缩侧索硬化症发生机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PAX3通过生肌调节因子调控椎旁肌异常发育在青少年特发性脊柱侧凸发病中的机制研究
- 批准号:82002260
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Air Pollution, Multidimensional Behavior, and Neuroimaging in Children with Neurodevelopmental Disorders
空气污染、多维行为和神经发育障碍儿童的神经影像学
- 批准号:
10644622 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria
一种互动式叙事干预措施,旨在解决尼日利亚艾滋病毒感染者年轻人的心理健康治疗差距
- 批准号:
10914342 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Using implementation mapping to maximize equity of school-based policies for obesity prevention
利用实施规划最大限度地提高基于学校的肥胖预防政策的公平性
- 批准号:
10572736 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别:
Risk and protective factors for Black youth suicide and suicidal ideation and behaviors
黑人青少年自杀以及自杀意念和行为的风险和保护因素
- 批准号:
10664624 - 财政年份:2023
- 资助金额:
$ 55.13万 - 项目类别: